| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.0073 | 0.8 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |